Project Grant R03OD038390

Award Date 9/5/24
Completion Date 9/4/25
Dollars Obligated $1
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports research to develop new computational methods and models for integrating single-cell 3D genomics data with other single-cell modalities. The $501,191.23 award, effective from September 2, 2024 to June 30, 2027, will fund the University of Texas MD Anderson Cancer Center's work to: Create a single-cell gene-body associating domain (SCGAD) scoring system to explore 3D...
The National Human Genome Research Institute (NHGRI) awarded a $400,000 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Washington to develop new single-cell multi-omic technologies for studying the relationship between three-dimensional genome organization and gene expression. Specifically, the grant will fund the development of CARE-Seq, a novel method to jointly measure whole-genome chromatin interactions and gene expression in the same single cells from complex...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) is providing $290,325 to the University of Illinois to develop advanced deep learning methods for estimating cell-type resolution and spatially-resolved gene regulatory networks from spatial transcriptomics data. The objectives are to: 1) Create machine learning models that can integrate regulatory network components and distinguish cell types...
This $653,880 Project Grant awarded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172) supports the development of a high-content, image-based CRISPR screening platform to discover regulators of three-dimensional (3D) genome architecture across multiple length scales. The goal is to advance screening technology to enable large-scale, multi-omic analysis of the spatial organization of the genome, nucleome, and transcriptome. Key...
This $292,727 Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports a research project by The Broad Institute, Inc. to discover novel regulators of 3D genome organization. The project aims to leverage large-scale genomic datasets to predict and experimentally validate new trans-acting factors that regulate chromatin interactions and genome architecture. By applying deep neural network models to in silico genetic...
The National Human Genome Research Institute (NHGRI) awarded a $1,350,896 Project Grant under the Human Genome Research program (CFDA 93.172) to the University of California, San Diego (UCSD) effective January 1, 2025 through December 31, 2028. The overarching goal of this research project is to develop novel technology based on massively parallel reporter barcoding strategies to enable simultaneous measurements of the effects of sequence perturbations on chromatin state, DNA-protein...
This two-year project grant from the National Science Foundation's Computer and Information Science and Engineering program aims to develop deep learning methods for high-resolution three-dimensional genome structure spatial reconstruction. With a total funding amount of $175,000, the award was issued on May 1, 2022 to the University of Colorado Colorado Springs to complete the project by April 30, 2024. The grantee will apply sophisticated and automated deep learning approaches to infer...
This $131,338 federal Project Grant award was provided by the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) to the University of Washington. The overarching goal of this 2-year award is to identify the functional consequences of variations in nuclear architecture on transcriptional and post-transcriptional regulation, and the role of this variation in human health and disease. Specifically, the award supports three research aims: 1) developing novel deep learning...
The National Human Genome Research Institute (NHGRI) awarded a $504,949 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Washington to develop advanced machine learning models that integrate Hi-C chromatin contact data with other genomics data types. The project aims to: 1) Extend the SAGITTARIUS model to analyze Hi-C time-series data and study the dynamic interplay between gene expression and chromatin structure during biological processes; 2) Develop a graph-based...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $890,066 to the University of Chicago to support research on the genetic and epigenetic controls of enhancer-promoter interactions in vertebrates. The research aims to: Identify the genetic instructions and processes that regulate the 3D folding of the genome and determine the specificity and efficiency of long-distance...

ULTRA-HIGH RESOLUTION 3D GENOME MAPS FOR MULTIPLE HUMAN TISSUES - ABSTRACT THE DIVERSITY OF HUMAN TISSUES AND CELL TYPES IS CONTROLLED BY DIFFERENTIAL REGULATION OF GENE EXPRESSION. ENHANCERS ARE THE PRIMARY UNITS OF GENE EXPRESSION CONTROL IN HUMANS, WHICH PHYSICALLY INTERACT WITH THE TARGET GENES TO ACTIVATE THEM. TO UNDERSTAND THE MECHANISM OF TRANSCRIPTIONAL REGULATION, SEVERAL LANDMARKING CONSORTIA HAVE ACCUMULATED LARGE AMOUNTS OF GENOMIC DATA. THE NIH COMMON FUND GTEX PROJECT HAS REVEALED TISSUE- SPECIFIC GENE EXPRESSION AND TRANSCRIPTIONAL REGULATION. THE NIH COMMON FUND 4D NUCLEOME (4DN) PROJECT HAS CHARACTERIZED 3D CHROMATIN INTERACTIONS IN MANY HUMAN TISSUES AND CELL TYPES. THE ENCODE PROJECT AND THE ROADMAP EPIGENOMIC PROJECT HAVE PROFILED TISSUE-SPECIFIC EPIGENOMIC STATES AND ANNOTATED THE REGULATORY ELEMENTS ACCORDINGLY. HOWEVER, OUR UNDERSTANDING OF HUMAN TRANSCRIPTIONAL REGULATION REMAINS LIMITED. A MAJOR CHALLENGE IN STUDYING ENHANCER-PROMOTER (E-P) INTERACTIONS IS THAT ENHANCERS ARE OFTEN LOCATED TENS TO HUNDREDS OF KILOBASES DISTAL TO THEIR TARGET GENES, YET MUST PHYSICALLY INTERACT WITH THEIR TARGET GENES TO ACTIVATE THEM. THEREFORE, TO UNDERSTAND GENE REGULATION IN HUMAN, A NECESSARY FIRST STEP IS TO PRECISELY MAP ALL E-P INTERACTIONS. HOWEVER, CURRENT 3D MAPS OF THE HUMAN GENOME REMAIN SPARSE AND NOISY AND FAIL TO DETECT THE VAST MAJORITY OF E-P INTERACTIONS. IN ADDITION, THE DATASETS GENERATED FROM THE COMMON FUND CONSORTIA ARE ISOLATED IN TERMS OF CELL TYPES AND TISSUE TYPES COVERED, HOW THE DATA ARE STORED, AND THE RESOLUTION OF THE GENOMIC DATA, RESULTING IN ADDITIONAL BARRIERS FOR INTEGRATIVE ANALYSIS. HERE WE PROPOSE TO COMBINE THE EXPERIMENTAL APPROACH, REGION CAPTURE MICRO-C, AND THE DEEP LEARNING ALGORITHMS TO ACCURATELY QUANTIFY E-P INTERACTIONS. THESE RESULTS ENHANCE THE CURRENT 3D MAPS FROM 4DN AND ENCODE PROJECTS. WE ALSO PLAN TO INTEGRATE EXPERIMENTAL AND IMPUTED E-P INTERACTIONS WITH NIH COMMON FUND DATA IN A KNOWLEDGE GRAPH. OUR KNOWLEDGE GRAPH WILL SUPPORT EFFICIENT CROSS-MODALITY QUERIES, GRAPH VISUALIZATION, AND CUSTOMIZED COMPUTATIONAL MODELING FOR INVESTIGATING QUANTITATIVE RULES IN TRANSCRIPTIONAL REGULATION. NOT ONLY WOULD THIS ACCOMPLISHMENT HAVE AN ENORMOUS POSITIVE IMPACT ON THE UTILITY AND USAGE OF THE COMMON FUND DATASETS, BUT IT WOULD ALSO HELP TO PROMOTE OPEN SCIENCE AND REPRODUCIBLE RESEARCH IN THE AREAS OF COMPUTATIONAL GENOMICS AND DATA SCIENCE.

Posted 9/5/24, 12:00 AM